What is a stock summary page? Click here for an overview.
Business Description
Abbisko Cayman Ltd
ISIN : KYG0028A1085
Compare
Compare
Traded in other countries / regions
02256.Hong Kong8ZD.Germany IPO Date
2022-01-04Description
Abbisko Cayman Ltd is an investment holding company that operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The company has only one business segment which is the development of innovative medicines.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 80.68 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.3 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 19.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 16.1 | |||||
| 3-Year EPS without NRI Growth Rate | 14.9 | |||||
| 3-Year FCF Growth Rate | -53.4 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 168.7 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 77.97 | |||||
| 9-Day RSI | 73.12 | |||||
| 14-Day RSI | 71.65 | |||||
| 3-1 Month Momentum % | 46.67 | |||||
| 6-1 Month Momentum % | 104.79 | |||||
| 12-1 Month Momentum % | 136.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 14.92 | |||||
| Quick Ratio | 14.92 | |||||
| Cash Ratio | 14.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 2.7 | |||||
| Shareholder Yield % | 1.33 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1.25 | |||||
| Net Margin % | 5.91 | |||||
| FCF Margin % | -12.74 | |||||
| ROE % | 1.47 | |||||
| ROA % | 1.37 | |||||
| ROIC % | -2.66 | |||||
| 3-Year ROIIC % | -529.47 | |||||
| ROC (Joel Greenblatt) % | 131.27 | |||||
| ROCE % | 3.97 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 202.3 | |||||
| PE Ratio without NRI | 202.3 | |||||
| PS Ratio | 10.73 | |||||
| PB Ratio | 2.72 | |||||
| Price-to-Tangible-Book | 2.69 | |||||
| EV-to-EBIT | 38.67 | |||||
| EV-to-EBITDA | 38.67 | |||||
| EV-to-Revenue | 6.24 | |||||
| EV-to-FCF | -45.05 | |||||
| Price-to-Graham-Number | 5 | |||||
| Price-to-Net-Current-Asset-Value | 2.84 | |||||
| Price-to-Net-Cash | 2.92 | |||||
| Earnings Yield (Greenblatt) % | 2.59 | |||||
| FCF Yield % | -1.36 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Abbisko Cayman Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 64.559 | ||
| EPS (TTM) (€) | 0.004 | ||
| Beta | 0.81 | ||
| 3-Year Sharpe Ratio | 0.4 | ||
| 3-Year Sortino Ratio | 0.65 | ||
| Volatility % | 35.89 | ||
| 14-Day RSI | 71.65 | ||
| 14-Day ATR (€) | 0.03371 | ||
| 20-Day SMA (€) | 0.9115 | ||
| 12-1 Month Momentum % | 136.2 | ||
| 52-Week Range (€) | 0.312 - 1.05 | ||
| Shares Outstanding (Mil) | 623.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Abbisko Cayman Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Abbisko Cayman Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Abbisko Cayman Ltd Frequently Asked Questions
What is Abbisko Cayman Ltd(STU:8ZD)'s stock price today?
The current price of STU:8ZD is €1.05. The 52 week high of STU:8ZD is €1.05 and 52 week low is €0.31.
When is next earnings date of Abbisko Cayman Ltd(STU:8ZD)?
The next earnings date of Abbisko Cayman Ltd(STU:8ZD) is .
Does Abbisko Cayman Ltd(STU:8ZD) pay dividends? If so, how much?
Abbisko Cayman Ltd(STU:8ZD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers